J. Safra Sarasin Holding’s Xenon Pharmaceuticals XENE Stock Holding History

J. Safra Sarasin Holding’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07M	Buy	17,750 +8,679	+96%	+$482K	0.02%	377
2026 Q1	$527K	Sell	9,071 -4,510	-33%	-$208K	0.01%	400
2025 Q4	$609K	Sell	13,581 -16,587	-55%	-$697K	0.01%	379
2025 Q3	$1.21M	Sell	30,168 -51,880	-63%	-$1.83M	0.02%	290
2025 Q2	$2.57M	Buy	82,048 +51,475	+168%	+$1.68M	0.04%	183
2025 Q1	$1.03M	Buy	30,573 +12,787	+72%	+$486K	0.02%	320
2024 Q4	$697K	Buy	+17,786	New	+$735K	0.01%	378

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

J. Safra Sarasin Holding's XENE Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its Xenon Pharmaceuticals (XENE) stake by 96% in Q2 2026, buying an estimated $482K and bringing the position to 17,750 shares worth $1.07M. The position accounts for 0.02% of the portfolio, ranked #377.

J. Safra Sarasin Holding first reported a position in XENE in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.57M in Q2 2025. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

J. Safra Sarasin Holding held 17,750 shares of Xenon Pharmaceuticals worth $1.07M as of Q2 2026.
J. Safra Sarasin Holding bought 8,679 Xenon Pharmaceuticals shares in Q2 2026, an estimated $482K.
Xenon Pharmaceuticals made up 0.02% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #377 holding.
J. Safra Sarasin Holding first reported a position in Xenon Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
J. Safra Sarasin Holding's Xenon Pharmaceuticals position peaked at $2.57M in Q2 2025.
315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.